| Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women (NCT03834571) | AIDS Malignancy Consortium | 2022-05-31 |
| Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer (NCT04574635) | Mayo Clinic | 2020-11-17 |
| Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer (NCT02921269) | National Cancer Institute (NCI) | 2017-03-10 |
| Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer (NCT02140021) | M.D. Anderson Cancer Center | 2014-10-27 |
| MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer (NCT01992861) | University of Washington | 2014-02-14 |
| Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer (NCT01711515) | National Cancer Institute (NCI) | 2012-10-01 |
| Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer (NCT01414608) | GOG Foundation | 2012-01-09 |
| Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer (NCT01266460) | Gynecologic Oncology Group | 2011-05-23 |
| Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical Cancer (NCT01295502) | Gynecologic Oncology Group | 2011-04-04 |
| Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer (NCT01267253) | Gynecologic Oncology Group | 2011-04-04 |
| Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer (NCT01281852) | National Cancer Institute (NCI) | 2011-03-14 |
| Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer (NCT01048853) | M.D. Anderson Cancer Center | 2010-04-15 |
| Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery (NCT01101451) | GOG Foundation | 2010-04-12 |
| Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer (NCT00369122) | National Cancer Institute (NCI) | 2006-08-11 |
| Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer (NCT00041093) | Gynecologic Oncology Group | 2002-06-01 |
| Collecting Tumor Samples From Patients With Gynecological Tumors (NCT00897442) | Gynecologic Oncology Group | 1992-06-01 |